Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Radiation Injuries × Androgen Antagonists × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 4 Urogenital Neoplasms 1 Radiation Injuries 1 Prostatic Diseases 1 Genital Neoplasms, Male 1 Adenocarcinoma of the Prostate 1

Interventions

Radiotherapy 4 Paclitaxel 3 Cisplatin 3 Amifostine 3 sodium propionate 1 ethanethiol 1 Topotecan 1 Radiation Protection 1 Pentetic Acid 1 Goserelin 1 Filgrastim 1 Fatty Acids, Volatile 1 Etoposide 1 Daclizumab 1 Carboplatin 1 Butyric Acid 1 Brachytherapy 1 Androgen Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05003752 2023-03-07

Hypo-Combi

German Oncology Center, Cyprus

Phase 1/2 Active not recruiting

Prostatic Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon ⚡